What you'll learn in this expert session
In these presentations, nurses will strengthen their immunisation knowledge and clinical practice using the latest evidence‑based insights from leading experts. This module supports nurses in applying current vaccine recommendations, making informed clinical decisions, and confidently managing immunisation‑related needs across all age groups with greater accuracy and safety.
In this edition, Angela Newbound, Immunisation Education Consultant, outlines key provider updates, including PCV21 supply constraints, COVID-19 vaccines moving to the NIP, influenza data and measles exposure management. Travel medicine expert, Dr Deb Mills, then discusses the latest global dengue incidence and reviews the newly TGA-approved vaccine, covering effectiveness, eligibility, side effects, cost and assessing travellers' risk.
About the Experts
Angela Newbound
Angela Newbound is a Registered Nurse and Immunisation Education Consultant based in South Australia, and has been delivering immunisation education and clinical support to general practice and other health professionals since 2000. She is a member of the Immunisation Coalition and provides clinical oversight of the PneumoSmart Vaccination Tool.
Dr Deb Mills
Dr Deb Mills has a passion for medicine and travel. She is the medical director of Dr Deb The Travel Doctor, and has been working in travel medicine since July 1988. She is one of the pioneers of Travel Medicine in Australia. This means she and her team have the expertise necessary to ensure you get the best travel medicine care possible. Dr Deb believes that travel and tourism can be a powerful force for good in the world, with the potential to benefit both the traveller, and those they visit. However, good health while travelling is essential for enjoying the adventure of travelling overseas. Her book ‘Travelling Well The ‘must-have’ guide to enjoying good health while you travel’ is now in its 21st edition, with over 215,000 copies in print. She is a regular on radio and television, and has been widely published on the subject of travellers’ health. As well as studying infectious diseases in Australia and many corners of the globe, she draws from her own travel experiences on all seven continents, to ensure travellers get the critical ‘been-there-done-that’ information that they need to travel with confidence and make the most of their journeys.
Takeda Pharmaceuticals Australia Pty Ltd has provided financial support towards this activity. October 2026.
